Puma Biotechnology (PBYI) Debt to Equity (2011 - 2026)
Puma Biotechnology (PBYI) reported Debt to Equity of $0.09 for Q1 2026, down 84.76% on a YoY basis from $0.58 in Q1 2025, and down 49.15% quarter-over-quarter from $0.17 in Q4 2025.
Puma Biotechnology (PBYI) Debt to Equity (2011 - 2026) Analysis & Trends
Puma Biotechnology has reported Debt to Equity for 9 years, with the latest figure at $0.09 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 84.76% year-over-year to $0.09; the trailing twelve-month figure through Mar 2026 stood at $0.09 (down 84.76% YoY), and the FY2025 full-year result was $0.17, down 76.26% from the prior year.
- Debt to Equity for Q1 2026 stood at $0.09, down from $0.17 in the prior quarter.
- The five-year high for Debt to Equity was $13.63 in Q1 2022, with the low at $0.09 in Q1 2026.
- Historically, Debt to Equity has averaged $2.72 across 5 years, with a median of $1.86 in 2023.
- Annual changes were most pronounced in 2022 — Debt to Equity jumped 149.91% — and 2026, when it tumbled 84.76%.
- Puma Biotechnology's Debt to Equity stood at $4.55 in 2022, then plunged by 59.01% to $1.86 in 2023, then sank by 60.97% to $0.73 in 2024, then plunged by 76.26% to $0.17 in 2025, then slumped by 49.15% to $0.09 in 2026.
- The last three Debt to Equity figures came in at $0.09 (Q1 2026), $0.17 (Q4 2025), and $0.29 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | 0.29 |
| Jun 30, 2025 | 0.43 |
| Mar 31, 2025 | 0.58 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 1.10 |
| Jun 30, 2024 | 1.84 |
| Mar 31, 2024 | 1.96 |
| Dec 31, 2023 | 1.86 |
| Sep 30, 2023 | 2.56 |
| Jun 30, 2023 | 3.26 |
| Mar 31, 2023 | 3.82 |
| Dec 31, 2022 | 4.55 |
| Sep 30, 2022 | 4.42 |
| Jun 30, 2022 | 4.95 |
| Mar 31, 2022 | 13.63 |
| Dec 31, 2021 | -39.69 |
| Sep 30, 2021 | -8.86 |
| Jun 30, 2021 | 3.40 |